NO875239D0 - Fremgangsmaate ved spalting av 1,4-dihydropyridinderivater i optisk aktive isomerer. - Google Patents

Fremgangsmaate ved spalting av 1,4-dihydropyridinderivater i optisk aktive isomerer.

Info

Publication number
NO875239D0
NO875239D0 NO875239A NO875239A NO875239D0 NO 875239 D0 NO875239 D0 NO 875239D0 NO 875239 A NO875239 A NO 875239A NO 875239 A NO875239 A NO 875239A NO 875239 D0 NO875239 D0 NO 875239D0
Authority
NO
Norway
Prior art keywords
division
procedure
active isomers
dihydropyridine derivatives
optic active
Prior art date
Application number
NO875239A
Other languages
English (en)
Other versions
NO875239L (no
Inventor
Gilles Genain
Original Assignee
Syntex Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Lab filed Critical Syntex Lab
Publication of NO875239D0 publication Critical patent/NO875239D0/no
Publication of NO875239L publication Critical patent/NO875239L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO875239A 1986-12-22 1987-12-15 Fremgangsmaate ved spalting av 1,4-dihydropyridinderivateri optisk aktive isomerer. NO875239L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/945,760 US4920225A (en) 1986-12-22 1986-12-22 Resolution of 1,4-dihydropyridine derivatives

Publications (2)

Publication Number Publication Date
NO875239D0 true NO875239D0 (no) 1987-12-15
NO875239L NO875239L (no) 1988-06-23

Family

ID=25483522

Family Applications (1)

Application Number Title Priority Date Filing Date
NO875239A NO875239L (no) 1986-12-22 1987-12-15 Fremgangsmaate ved spalting av 1,4-dihydropyridinderivateri optisk aktive isomerer.

Country Status (13)

Country Link
US (1) US4920225A (no)
EP (1) EP0273349A3 (no)
JP (1) JPS63185960A (no)
KR (1) KR880007469A (no)
AU (1) AU8284887A (no)
DK (1) DK674287A (no)
FI (1) FI875623A (no)
GB (1) GB2200631A (no)
HU (1) HUT45499A (no)
IE (1) IE873469L (no)
IL (1) IL84894A0 (no)
NO (1) NO875239L (no)
ZA (1) ZA879579B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3737340A1 (de) * 1987-11-04 1989-05-24 Bayer Ag Neue fluormethoxyphenyl-dihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
GB8804630D0 (en) * 1988-02-27 1988-03-30 Pfizer Ltd Preparation of r-& s-amlodipine
IT1230752B (it) * 1989-02-17 1991-10-29 Boehringer Biochemia Srl Processo per la preparazione di 1,4 diidropiridine polisostituite in forma enantiomericamente pura.
EP0398617A3 (en) * 1989-05-15 1991-11-06 Merck Sharp & Dohme Ltd. Process for resolving 1-azabicyclo [2.2.1]heptane-3-carboxylates
JPH03141257A (ja) * 1989-10-26 1991-06-17 Green Cross Corp:The ジヒドロピリジン誘導体
US5100892A (en) * 1990-11-13 1992-03-31 Glaxo Inc. Dihydropyridine vasodilator agents
US5135936A (en) * 1991-03-05 1992-08-04 Marion Merrell Dow Inc. Isomers of 1-azabicyclo[2.2.2]oct-3-yl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinediacarboxylic and their use as calcium antagonists
US5210398A (en) * 1991-06-14 1993-05-11 Symbol Technologies, Inc. Optical scanner with extended depth of focus
FR2719585B1 (fr) * 1994-05-05 1996-08-02 Lafon Labor Procédé d'obtention de 1,4-dihydropyridines optiquement pures.
AU5568300A (en) * 1999-06-23 2001-01-09 Ajinomoto Co., Inc. Novel dihydropyridine derivative
WO2002032878A1 (en) * 2000-10-13 2002-04-25 Eli Lilly And Company Resolution process for preparation of substantially pure (r) and (s) enantiomers of 2-(4-nitroimidazolyl)-4-methoxyphenylpropionic acid and salts thereof
AU2004285962A1 (en) * 2003-11-03 2005-05-12 Myogen, Inc. 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease
DE602004016547D1 (de) 2003-11-03 2008-10-23 Myogen Inc 1,4-dihydropyridinverbindungen, pharmazeutische verbindungen, und verfahren zur behandlung von herzkreislauferkrankungen

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370334A (en) * 1975-07-02 1983-01-25 Fujisawa Pharmaceutical Co., Ltd. 1,4-Dihydro-pyridine derivatives and methods of using same
SE442298B (sv) * 1978-06-30 1985-12-16 Haessle Ab 2,6-dimetyl-4-(2,3-diklorfenyl)-1,4-dihydropyridin-3,5-dikarboxylsyra-3-metylester-5-etylester i optisk aktiv form
SE429652B (sv) * 1978-06-30 1983-09-19 Haessle Ab 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
CS228917B2 (en) * 1981-03-14 1984-05-14 Pfizer Method of preparing substituted derivatives of 1,4-dihydropyridine
ZA83959B (en) * 1982-03-10 1984-09-26 Sandoz Ltd 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
JPS58208271A (ja) * 1982-04-30 1983-12-03 Kyowa Hakko Kogyo Co Ltd 1,4−ジヒドロピリジン誘導体
FR2528431B1 (fr) * 1982-06-15 1986-01-10 Sandoz Sa Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments
DE3247118A1 (de) * 1982-12-20 1984-06-20 Cassella Ag, 6000 Frankfurt Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
JPS59161392A (ja) * 1983-03-04 1984-09-12 Nippon Shinyaku Co Ltd ジヒドロピリジン誘導体及びその製法
CA1339372C (en) * 1983-09-26 1997-08-26 Nissan Chemical Industries Ltd. Dihydropyridine-5-phosphonic acid cyclic ester
GB8412208D0 (en) * 1984-05-12 1984-06-20 Pfizer Ltd Quinolone inotropic agents
DE3423105A1 (de) * 1984-06-22 1986-01-02 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung optisch aktiver 1,4-dihydropyridine
IL77843A (en) * 1985-02-11 1989-07-31 Syntex Inc Dihydropyridine derivatives,process and novel intermediates for their preparation and pharmaceutical compositions containing them
US4595690A (en) * 1985-02-11 1986-06-17 Syntex (U.S.A.) Inc. Antihypertensive dihydropyridine derivatives
US4761420A (en) * 1986-06-13 1988-08-02 Laboratoires Syntex S.A. Antihypertensive dihydropyridine derivatives

Also Published As

Publication number Publication date
AU8284887A (en) 1988-06-23
KR880007469A (ko) 1988-08-27
DK674287D0 (da) 1987-12-21
EP0273349A2 (en) 1988-07-06
NO875239L (no) 1988-06-23
FI875623A (fi) 1988-06-23
JPS63185960A (ja) 1988-08-01
US4920225A (en) 1990-04-24
ZA879579B (en) 1989-08-30
GB2200631A (en) 1988-08-10
IE873469L (en) 1988-06-22
FI875623A0 (fi) 1987-12-21
GB8729735D0 (en) 1988-02-03
HUT45499A (en) 1988-07-28
DK674287A (da) 1988-06-23
EP0273349A3 (en) 1990-02-14
IL84894A0 (en) 1988-06-30

Similar Documents

Publication Publication Date Title
NO871408D0 (no) Forbedringer ved farmasoeytiske akseptable salter.
NO885106L (no) Fremgangsmaate ved fremstilling av cytidin-derivater.
NO173544C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2- tiometyl-substituerte 1,4-dihydropyridiner
NO159089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater.
NO872831D0 (no) Fremgangsmaate for fremstilling av nitrofuranderivater.
TR23424A (tr) 1,2,3,6-tetrahidro-5-nitro-pirimidin tuerevleri
NO166083C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridazodiazepinderivater.
NO875239D0 (no) Fremgangsmaate ved spalting av 1,4-dihydropyridinderivater i optisk aktive isomerer.
IT8720200A0 (it) Agenti stabilizzanti costituiti da 1,3,2-ossazafosfolidine.
IT8547683A0 (it) Procedimento per la preparazione dicomposti 1,3-diossolan-4-metanolici otticamente attivi
NO168107C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,4-dihydropyridiner
NO166326C (no) Fremgangsmaate ved fremstilling av terapeutisk aktive 3,7-substituerte-8-oxo-5-thia-1-azabicyclo-(4,2,0)oct-2-en-2-carboxylater.
NO171909C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
NO162717C (no) Fremgangsmaate ved fremstilling av optisk aktivt carnitrinnitrillklorid.
FI873429A (fi) Oftalmologiska kompositioner foer behandling av nervdegenerationer.
FI895662A0 (fi) Menetelmä 3,4-difluorisubstituoidun benseenin valmistamiseksi
NO862390D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater.
DK142287A (da) Optisk aktive 1,4-dihydropyridinderivater
FI891111A (fi) Menetelmä 1,4-dihydropyridiinijohdannaisten valmistamiseksi
PT86623A (pt) Process for the preparation of derivatives of 3-aryl-5-alkylthio-4h-1,2,4-triazoles
FI860247A (fi) Foerfarande foer framstaellning av 4,4-dialkyl-2-azetidinoner.
FI93725B (fi) Menetelmä optisesti aktiivisten, oikealle kiertävien okso-isoindolinyylijohdannaisten valmistamiseksi
ES546387A0 (es) Procedimiento pra la preparacion de 1,4-dihidropiridinas sustituidas,opticamente activas
NO157575C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,4-dihydropyridin-derivater.
DE68906449D1 (de) Herstellung von 2,6-dioxopiperidinderivate.